← All patents

US20050287543A1

Diagnostic and therapeutic methods and compositions involving PTEN and breast …

University of Texas System

Abstract

Patients with ErbB2-overexpressing cancers can be given an ErbB2 targeting agent as a therapeutic regimen but not all patients are responsive. The present invention concerns the diagnostic, prognostic and therapeutic methods and compositions for evaluating potential efficacy of an ErbB2 targeting …

University
University of Texas System
Assignee
University Of Texas M.D. Anderson Center
Inventor
Dihua Yu
Priority date
November 05, 2003
Filing date
November 05, 2004
Publication date
December 29, 2005
Language
en
Metadata fetched
August 28, 2026 23:58